Melbourne scientists develop breakthrough flu puffer to prevent deadly pneumonia

Melbourne scientists developed an experimental flu puffer aimed at preventing serious complications from influenza, potentially reducing cases of bacterial pneumonia. The treatment, LAT9997, successfully limited lung damage in mice with just two doses. Researchers anticipate human trials to confirm effectiveness and hope to create an inhaler for those at high risk of severe illness.

Read full article on 7 News →

Summary by Glance · Original reporting by 7 News